[Translated article] Longitudinal Study of Different Progression Patterns in High-Risk Cutaneous Squamous Cell Carcinoma

被引:0
|
作者
Tejera-Vaquerizo, A. [1 ,2 ]
Canueto, J. [3 ]
Gomez-Tomas, A. [4 ]
Santos-Juanes, J. [5 ]
Ribero, S. [6 ]
Avallone, G. [6 ]
Jaka, A. [7 ]
Ferrandiz-Pulido, C. [4 ]
Toll, A. [8 ]
Sanmartin, O. [9 ]
机构
[1] Hosp San Juan Dios, Unidad Oncol Cutanea, Cordoba, Spain
[2] Inst Dermatol GlobalDerm, Serv Dermatol, Palma Del Rio, Cordoba, Spain
[3] Complejo Asistencial Univ Salamanca, Serv Dermatol, Salamanca, Spain
[4] Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Serv Dermatol, Barcelona, Spain
[5] Univ Oviedo, Hosp Cent Asturias Inst Invest Sanitaria Principad, Serv Dermatol, IUOPA, Oviedo, Spain
[6] Univ Turin, Med Sci Dept, Sect Dermatol, Turin, Italy
[7] Univ Autonoma Barcelona, Hosp Univ Germans Trials & Pujol, Inst Invest Germans Trias & Pujol, Serv Dermatol, Badalona, Barcelona, Spain
[8] Univ Barcelona, Hosp Clin, Serv Dermatol, Barcelona, Spain
[9] Inst Valenciano Oncol, Serv Dermatol, Valencia, Spain
来源
ACTAS DERMO-SIFILIOGRAFICAS | 2024年 / 115卷 / 07期
关键词
Cutaneous squamous cell carcinoma; Prognosis; Neoplastic metastasis; Lymphatic metastasis; Disease progression; CANCER METASTASIS; NODE BIOPSY; LYMPHADENECTOMY;
D O I
10.1016/j.ad.2024.05.016
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background and objective: Cutaneous squamous cell carcinoma (cSCC) is the second leading cause of skin cancer mortality in Europe. Few studies have analyzed the different pathways of this tumor progression in its natural history. The main objective of this study was to analyze the different metastatic and progression pathways and their temporal occurrence in the evolution of cSCC. Material and method: We conducted a multicenter, retrospective, and observational study of consecutive high -risk sSCCs included in the SQUAMATA project. Results: A total of 222 out of the 1346 patients included relapsed. The most frequent route of progression was the lymphatic one (62.6%). A total of 20.2% of the cases with lymphatic progression developed distant metastases. Only 1 case (3.1%) of distant metastasis followed local recurrence without previous lymphatic metastasis. The median time to disease -related mortality was longer in patients who developed systemic metastases than in those who died of locoregional progression.
引用
收藏
页码:T670 / T678
页数:9
相关论文
共 50 条
  • [31] Squamous cell carcinoma: from precursor lesions to high-risk variants
    Smoller, BR
    MODERN PATHOLOGY, 2006, 19 : S88 - S92
  • [32] Sentinel lymph node biopsy for high-risk cutaneous squamous cell carcinoma: Analysis of recurrence-free survival
    Samsanavicius, Donatas
    Kaikaris, Vygintas
    Norvydas, Simonas-Jonas
    Liubauskas, Rokas
    Valiukeviciene, Skaidra
    Makstiene, Jurgita
    Maslauskas, Kestutis
    Rimdeika, Rytis
    MEDICINA-LITHUANIA, 2016, 52 (05): : 276 - 282
  • [33] Clinicopathological characteristics and clinical morbidity in high-risk head and neck cutaneous squamous cell carcinoma patients in Western Australia
    Grover, Piyush
    Flukes, Stephanie
    Jacques, Angela
    Leedman, Samuel
    Lindsay, Andrew
    White, Rohen
    Friedland, Peter
    Gurfinkel, Reuven
    Lim, Annette M.
    INTERNAL MEDICINE JOURNAL, 2022, 52 (06) : 944 - 951
  • [34] Validation of a 40-gene expression profile test to predict metastatic risk in localized high-risk cutaneous squamous cell carcinoma
    Wysong, Ashley
    Newman, Jason G.
    Covington, Kyle R.
    Kurley, Sarah J.
    Ibrahim, Sherrif F.
    Farberg, Aaron S.
    Bar, Anna
    Cleaver, Nathan J.
    Somani, Ally-Khan
    Panther, David
    Brodland, David G.
    Zitelli, John
    Toyohara, Jennifer
    Maher, Ian A.
    Xia, Yang
    Bibee, Kristin
    Griego, Robert
    Rigel, Darrell S.
    Plasseraud, Kristen Meldi
    Estrada, Sarah
    Sholl, Lauren Meldi
    Johnson, Clare
    Cook, Robert W.
    Schmults, Chrysalyne D.
    Arron, Sarah T.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 84 (02) : 361 - 369
  • [35] Risk Factors and Prognosis for Metastatic Cutaneous Squamous Cell Carcinoma: A Cohort Study
    Knuutila, Jaakko S.
    Riihila, Pilvi
    Kurki, Samu
    Nissinen, Liisa
    Kahari, Veli-Matti
    ACTA DERMATO-VENEREOLOGICA, 2020, 100 : 1 - 9
  • [36] Node-positive cutaneous squamous cell carcinoma of the head and neck: Survival, high-risk features, and adjuvant chemoradiotherapy outcomes
    Amoils, Misha
    Lee, Carolyn S.
    Sunwoo, John
    Aasi, Sumaira Z.
    Hara, Wendy
    Kim, Jinah
    Sirjani, Davud
    Colevas, A. Dimitrios
    Chang, Anne Lynn S.
    Divi, Vasu
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2017, 39 (05): : 881 - 885
  • [37] Relationship between PD-L1 expression and prognostic factors in high-risk cutaneous squamous and basal cell carcinoma
    Yulek, Ozden
    Batur, Sebnem
    Ozcan, Kerem
    Yol, Cansu
    Ulgen, Ovgu Aydin
    BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2022, 22 (06) : 894 - 900
  • [38] Significant Biomarkers Identification Associated with Cutaneous Squamous Cell Carcinoma Progression
    Qiu, Cheng-Gang
    Shen, Bin
    Sun, Xiao-Qi
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2022, 15 : 2347 - 2360
  • [39] Inferior outcomes in immunosuppressed patients with high-risk cutaneous squamous cell carcinoma of the head and neck treated with surgery and radiation therapy
    Manyam, Bindu V.
    Gastman, Brian
    Zhang, Alexandra Y.
    Reddy, Chandana A.
    Burkey, Brian B.
    Scharpf, Joseph
    Alam, Daniel S.
    Fritz, Michael A.
    Vidimos, Allison T.
    Koyfman, Shlomo A.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 73 (02) : 221 - 227
  • [40] Management of the parotid for high-risk cutaneous squamous cell carcinoma: A review from the salivary section of the American Head and Neck Society
    Kejner, Alexandra E.
    Harris, Brianna N.
    Patel, Rusha
    McMullen, Caitlin
    Weir, Joshua
    Dahshan, Basem A.
    Carroll, William R.
    Gillespie, M. Boyd
    AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2022, 43 (02)